Cascadian Therapeutics, Inc.

Cascadian Therapeutics, Inc.

Cascadian Therapeutics, Inc.

Cascadian Therapeutics is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients.
Follow us
Alexa global traffic share
Team Size
50+
Employees
GeekWire

Seattle Genetics finds mixed success in first earnings after Cascadian Therapeutics acquisition

Earnings Health
GeekWire

Seattle Genetics to acquire Cascadian Therapeutics for $614M to further bolster its cancer fight

Health
Xconomy

Bio Buyout Spree Continues as SeaGen Bets $614M on Cascadian Cancer Drug

Health Strategy